Linear mixed‐effects models for central statistical monitoring of multicenter clinical trials
暂无分享,去创建一个
C Legrand | L Desmet | D Venet | E Doffagne | C Timmermans | T Burzykowski | M Buyse | M. Buyse | C. Legrand | T. Burzykowski | D. Venet | E. Doffagne | C. Timmermans | L. Desmet
[1] Canary Wharf,et al. Reflection paper on risk based quality management in clinical trials , 2013 .
[2] D J Spiegelhalter,et al. Flexible random‐effects models using Bayesian semi‐parametric models: applications to institutional comparisons , 2007, Statistics in medicine.
[3] P. Lachenbruch,et al. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. , 1999, Statistics in medicine.
[4] Tomasz Burzykowski,et al. A statistical approach to central monitoring of data quality in clinical trials , 2012, Clinical trials.
[5] Peter Sandercock,et al. Sensible approaches for reducing clinical trial costs , 2008, Clinical trials.
[6] I. Guttman. Care and Handling of Univariate or Multivariate Outliners in Detecting Spuriosity—a Bayesian Approach , 1973 .
[7] Taghrid Obied,et al. Oversight of clinical investigations- A risk based approach to monitoring , 2014 .